Clinical Trials in Michigan

Showing 13581-13600 of 13,890 trials

A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis

NCT00281294

To evaluate the efficacy of fontolizumab in subjects with active rheumatoid arthritis as determined by a 50% improvement of an American College of Rheumatology criteria (ACR50) response at Week 14 (Stage A of study).

Arthritis, Rheumatoid

PDL BioPharma, Inc.40 participantsStarted Dec 2005

Los Angeles, California, United States • Palo Alto, California, United States • Denver, Colorado, United States +6 more locations

COMPLETEDPhase 441 miles

Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients

NCT00650455

The objectives of the study were to evaluate the efficacy, safety, and tolerability of valdecoxib 10 mg once daily (QD) or naproxen 500 mg twice daily (BID) versus placebo, and to assess the efficacy of valdecoxib 10 mg QD versus naproxen 500 mg BID, in treating the signs and symptoms of rheumatoid arthritis (RA) in a severe Rheumatoid Arthritis population.

Arthritis, Rheumatoid

Pfizer489 participantsStarted Feb 2003

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Glendale, Arizona, United States +52 more locations

A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis

Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients

Find Trials by Condition in Michigan

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

High Intensity Focused Ultrasound (HIFU) Ablation System Study

Biomarkers in Acute Heart Failure

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease

Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

A Blood Test to Look at Cells of the Immune System in Healthy Children

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD